
Articles
Filter
- Articles
Education policy changes: accountability reform
03 Apr 2025The Labour government has introduced several significant policy changes with the aim of improving educational outcomes, particularly for disadvantaged and vulnerable children.- Articles
Sustainability - why this is now crucial for pharma business leaders?
01 Apr 2025Whether your business is in early stage drug discovery and R&D or manufacturing, supply, and distribution, every part of the pharma ecosystem is now under increasing pressure to adopt sustainable practices.- Articles
Spending on medicines and medical devices increases but VPAG clawback reach record levels
01 Apr 2025NHS spending on medicines, appliances and medical devices in England hit £19.9bn in 2023/24, with £14.6bn in branded medicine sales. However, the VPAG clawback is meanwhile expected to be an unprecedented £3.5bn in 2025, £1bn more than previously forecast- Articles
NHS England abolished - what does this mean for pharma?
01 Apr 2025This is not about abolishing the NHS, but a plan to redirect money from bureaucracy to frontline treatments of patients.- Articles
Employment Rights Bill: recent amendments and where we are now
31 Mar 2025Since being introduced in October 2024, the Employment Rights Bill has undergone significant amendments, introducing new provisions and revising existing ones to enhance worker protections and clarify employer obligations.- Articles
AI & Copyright Law: comparing global approaches
31 Mar 2025A comparative analysis of how interests are being balanced in the UK, EU, US and Japan.